TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | 1 | -18 | -38 | -45 | -48 | -25 |
| S | %wins | 50 | 50 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/15/15 16:17 | 7/13/15 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Saluri Joseph | IA | D | M.d | 41 | 8.19 | 21 | 5 | 45 | 16 | D | 178 | 126 | 27 | -8 | 19 | 12 | 21 | 17 | 4 | 4 | -9 | -36 | -47 | -80 | ||
7/15/15 16:17 | 7/13/15 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Saluri Joseph | IA | D | S.d | -252 | 50.42 | 21 | -5 | -24 | 16 | D | 178 | 126 | 27 | -8 | 19 | 12 | 21 | 17 | 4 | 4 | -9 | -36 | -47 | -80 | ||
2/11/14 18:11 | 2/7/14 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Saluri Joseph | IA | D | M.d | 15 | 3.07 | 22 | 5 | 75 | 11 | D | 448 | 242 | 140 | 149 | 84 | 20 | 14 | 18 | -5 | -3 | -26 | -40 | -42 | -16 | ||
2/11/14 18:11 | 2/7/14 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Saluri Joseph | IA | D | S.d | -185 | 38.80 | 22 | -5 | -30 | 11 | D | 448 | 242 | 140 | 149 | 84 | 20 | 14 | 18 | -5 | -3 | -26 | -40 | -42 | -16 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |